消除黄热病流行全球战略

更新于 2026年11月17日 版权声明
三、消除黄热病流行全球战略

YF在非洲和南美洲地区的大范围再流行对该地区国家公共卫生的威胁以及由此造成的YF在国际间流行的威胁不断加大,引起全世界的广泛关注。2016年9月,WHO联合全球疫苗联盟(GAVI)、疫苗联盟和联合国儿童基因会(UNICEF)等多个国际合作组织的专家对YF在全球再流行的形式和趋势进行了评估,发布了消除黄热病流行(Eliminate yellow fever epidemics,EYE)全球战略。EYE的战略目标是到2026年全球消除黄热病流行,为此采取3个策略:①保护高危人群。②防止YF在国际间传播。③迅速遏制YF的暴发流行。

黄热病疫苗接种计划主要针对最容易受到YF疫情影响的国家和地区,即YF高危流行区,包括27个非洲国家和13个南美洲国家,预计在2017~2026年10年间将接种13.8亿剂YF疫苗,大规模疫苗接种可形成当地成人和儿童群体中对黄热病毒感染的免疫屏障。除了在非洲和南美洲黄热病流行地区实施黄热疫苗常规疫苗接种计划以外,还需要采取全球行动来应对YF可能蔓延到非洲和南美洲以外的城市和地区,减少YF对非流行区造成新的威胁。此外,还要加强国际卫生条例的实施,加强实验室诊断能力,保护进出高风险地区的旅行者和务工人员,通过有效的数据整合和信息共享改进蚊媒和疾病监测等。为确保EYE战略成功实施,WHO认为YF疫苗接种要注意以下事项:①廉价可持续的黄热疫苗的市场供应,以及应对黄热疫苗需求激增的机制。②加强对公众的宣传以促进区域性和国家政府层面的支持。③建立健全YF综合治理,加强监测。④多部门协作。⑤研究开发更好的疫苗接种工具等。

(邓艳琴)

参考文献

[1]Gotuzzo E,Yactayo S,Cordova E.Efficacy and duration of immunity after yellow fever vaccination:systematic review on the need for a booster every 10 years[J].Am J Trop Med Hyg,2013,89(3):433-444.

[2]Wang L,Zhou P,Fu X,et al.Yellow fever virus:increasing imported cases in China[J].J Infect,2016,73(4):377-380.

[3]Jana J von Lindern,Sarah A,Nicholas DB,et al.Genome analysis and phylogenetic relationships between east,central and west African isolates of yellow fever virus[J].J Gen Virol,2006,87( Pt 4):895-907.

[4]WHO.Yellow fever surveillance-Africa[J].MMWR,1982,31(33):452-453.

[5]WHO.Expert committee on yellow fever[R].3rd Report.WHO Tech Rep,1971:479.

[6]Barbaud A,Deschildre A,Waton J.Hypersensitivity and vaccines:an update[J].Eur J Dermatol,2013,23(2):135-141.

[7]Barrett A.Epidemiology and ecology of yellow fever virus[J].Adv Virus Res,2003,61:291-315.

[8]Monath TP,Barrett AD.Pathogenesis and pathophysiology of yellow fever[J].Adv Virus Res,2003,60:343-395.

[9]Monath TP,Woodall JP,Gubler DJ,et al.Yellow fever vaccine supply:a possible solution[J].Lancet,2016,387(10028):1599-1600.(https://www.daowen.com)

[10]Julander JG,Shafer K,Smee DF,et al.Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound,T-1106[J].Antimicrob Agents Chemother,2009,53(1):202-209.

[11]Furuta Y,Gowen BB,Takahashi K,et al.Favipiravir (T-705),a novel viral RNA polymerase inhibitor[J].Antiviral Res,2013,100(2):446-454.

[12]Caroline AL,Powell DS,Bethel LM,et al.Broad spectrum antiviral activity of favipiravir (T-705):protection from highly lethal inhalational Rift Valley Fever[J].PLoS Negl Trop Dis,2014,8(4):e2790.

[13]Safronetz D,Rosenke K,Westover JB,et al.The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset[J].Sci Rep,2015,5:14775.

[14]Gowen BB,Juelich TL,Sefing EJ,et al.Favipiravir (T-705)inhibits Junín virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever[J].PLoS Negl Trop Dis,2013,7(12):e2614.

[15]Gowen BB,Sefing EJ,Westover JB,et al.Alterations in favipiravir (T-705)pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever[J].Antiviral Res,2015,121:132-137.

[16]Mastrangelo E,Pezzullo M,De Burghgraeve T,et al.Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity:new prospects for an old drug[J].J Antimicrob Chemother,2012,67(8):1884-1894.

[17]Patkar CG,Larsen M,Owston M,et al.Identification of inhibitors of yellow fever virus replication using a replicon-based highthroughput assay[J].Antimicrob Agents Chemother,2009,53(10):4103-4114.

[18]Julander JG,Furuta Y,Shafer K,et al.Activity of T-1106 in a hamster model of yellow Fever virus infection[J].Antimicrob Agents Chemother,2007,51(6):1962-1966.

[19]Waggoner JJ,Rojas A,Pinsky BA.Yellow Fever Virus:Diagnostics for a Persistent Arboviral threat[J].J Clin Microbiol,2018,56(10):e00827-18.

[20]Deng YQ,Dai JX,Ji GH,et al.A broadly flavivirus crossneutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein[J].PLoS One,2011,6(1):e16059.

[21]Mayhoub AS,Khaliq M,Kuhn RJ,et al.Design,synthesis,and biological evaluation of thiazoles targeting flavivirus envelope proteins[J].J Med Chem,2011,54(6):1704-1714.

[22]WHO.Eliminate Yellow Fever Epidemics(EYE):a global strategy,2017- 2026[EB/OL].(2016-09-26)[2019-06-05].https://apps.who.int/iris /bitstream/hand le/10665/272408/9789241513661-eng.pdf

✍AI写作